U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
LINTUZUMAB
V00Y10W60W
Investigational
General
Record Details
Names
8
Classification
6
Identifiers
8
Subunits
4
Disulfide Links
16
Relationships
1
Active Moiety
1
Characteristic Attributes
2
LINTUZUMAB
V00Y10W60W
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
HUMANIZED MOUSE
Sequence Type
COMPLETE
Record UNII
V00Y10W60W
Record Status
Validated (UNII)
Record Version
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
LINTUZUMAB
Official Name
English
SGN-33
Code
English
HUM195
Code
English
HUMA-195-GELONIN
Code
English
HUM-195
Code
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of acute myeloid leukemia.
FDA ORPHAN DRUG
235106
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of acute myelogenous leukemia
FDA ORPHAN DRUG
158502
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of myelodysplastic syndrome
FDA ORPHAN DRUG
238007
Withdrawn
EU ORPHAN DRUG
Withdrawn
Treatment of acute myeloid leukaemia
EU-Orphan Drug
EU/3/09/627
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
166089-32-3
PRIMARY
NCI_THESAURUS
C1716
PRIMARY
ChEMBL
CHEMBL2109150
PRIMARY
EVMPD
SUB02929MIG
PRIMARY
WIKIPEDIA
LINTUZUMAB
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Disulfide Links
16
Show
5
20
100
All
entries
From
To
From
To
1_22
1_96
1_143
1_199
1_219
3_218
1_225
2_225
1_228
2_228
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
HX0GZ7OLW5
MYELOID CELL SURFACE ANTIGEN CD33
TARGET -> INHIBITOR
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
V00Y10W60W
LINTUZUMAB
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
C6440H9922N1712O2026S46
MOL_WEIGHT:ESTIMATED
CHEMICAL
ESTIMATED 145000 DA (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
